Cheav S L, Delcayre C, Besnard J C, Paolaggi F, Mouas C, Swynghedauw B
U 127 INSERM, Hôpital Lariboisière, Paris, France.
Arch Int Pharmacodyn Ther. 1991 Nov-Dec;314:5-24.
The aim of this study was to see if an enhanced myocardial stiffness is an inevitable consequence of the increase in cardiac mass and to analyze the effects of beta-adrenergic blockade on this parameter. The DOCA-salt model of hypertension was used to induce cardiac hypertrophy in the rat. After 6 weeks, the hearts of the DOCA-salt-treated animals were hypertrophied by 67%, and the left ventricular weight, the left ventricular/body weight ratio and the left/right ventricular weight ratio were similarly increased. Isolated hearts were retrogradely perfused at a constant flow of 15 ml/min/g tissue. Contractile parameters were recorded using an intraventricular balloon whose volume was manually adjusted. For each heart, a sequence of three systolic and diastolic pressure-volume curves were constructed: in Krebs alone, after addition of 10(-6) M of propranolol, and after KCl-arrest. In spite of a pronounced degree of hypertrophy, the DOCA-salt hearts had a normal diastolic pressure-volume curve and both the chamber and tissue stiffness constants were not modified. This result indicates that a depressed compliance does not necessarily accompany hypertrophy, especially in a DOCA-salt model in which the collagen content of the heart is unchanged. The systolic pressure-volume curve was greatly modified and shifted to the left indicating an enhanced capacity of the hypertrophied heart to generate force. This increase persisted even when the systolic pressure has been divided by the heart weight. beta-Blockade slightly depressed the contractility of the isolated heart at pharmacological concentrations. At high concentrations, cardiac dilatation was induced. This enhancement in ventricular distensibility had no consequences on diastolic compliance constants. It is thus concluded that, during cardiac hypertrophy, the changes in passive stiffness of the ventricle are more related to collagen content than to the cardiac mass and that beta-adrenergic blockade has no effect on the passive properties of the ventricle.
本研究的目的是观察心肌僵硬度增强是否是心脏质量增加的必然结果,并分析β-肾上腺素能阻滞剂对该参数的影响。采用去氧皮质酮-盐高血压模型诱导大鼠心脏肥大。6周后,去氧皮质酮-盐处理组动物的心脏重量增加了67%,左心室重量、左心室/体重比和左/右心室重量比也同样增加。将离体心脏以15 ml/min/g组织的恒定流量进行逆行灌注。使用一个可手动调节容积的心室内球囊记录收缩参数。对于每颗心脏,构建了一组三条收缩期和舒张期压力-容积曲线:仅在 Krebs 液中、加入10(-6) M 普萘洛尔后以及氯化钾停跳后。尽管肥大程度明显,但去氧皮质酮-盐处理的心脏舒张期压力-容积曲线正常,心室和组织僵硬度常数均未改变。这一结果表明,顺应性降低不一定伴随肥大,尤其是在心脏胶原含量未改变的去氧皮质酮-盐模型中。收缩期压力-容积曲线发生了显著改变并向左移位,表明肥大心脏产生力的能力增强。即使将收缩压除以心脏重量,这种增加仍然持续。β-阻滞剂在药理浓度下轻微降低了离体心脏的收缩性。在高浓度时,会诱导心脏扩张。心室扩张性的这种增强对舒张期顺应性常数没有影响。因此得出结论,在心脏肥大过程中,心室被动僵硬度的变化与胶原含量的关系比与心脏质量的关系更大,并且β-肾上腺素能阻滞剂对心室的被动特性没有影响。